| Q46861382 | Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? |
| Q35093793 | Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy |
| Q33658821 | Arylhydrocarbon receptor activation in NCI-H441 cells and C57BL/6 mice: possible mechanisms for lung dysfunction |
| Q58763415 | Characterization of a lung epithelium specific E-cadherin knock-out model: Implications for obstructive lung pathology |
| Q40391025 | E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells |
| Q90053659 | EGFR activation-induced decreases in claudin1 promote MUC5AC expression and exacerbate asthma in mice |
| Q47952289 | Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. |
| Q36192954 | Effects of second hand smoke on airway secretion and mucociliary clearance |
| Q36032652 | Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. |
| Q93091807 | Emerging Concepts and Therapies for Mucoobstructive Lung Disease |
| Q36458412 | Emerging drugs for the treatment of chronic obstructive pulmonary disease |
| Q44447879 | Epidermal growth factor receptor - but not histamine receptor - is upregulated in seasonal allergic rhinitis |
| Q44583871 | Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation |
| Q39343736 | Histamine regulates mucin expression through H1 receptor in airway epithelial cells |
| Q35228086 | IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease |
| Q28568180 | IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway |
| Q36120008 | Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study |
| Q38882099 | Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. |
| Q36229545 | MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation |
| Q55401303 | New targets for resolution of airway remodeling in obstructive lung diseases. |
| Q35885857 | Prospects for new drugs for chronic obstructive pulmonary disease |
| Q24683215 | SPDEF regulates goblet cell hyperplasia in the airway epithelium |
| Q42464328 | Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease |
| Q36407059 | Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study |
| Q37290288 | The Epithelial Cell in Lung Health and Emphysema Pathogenesis |
| Q54636790 | The Rac1/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells |
| Q35017715 | The airway goblet cell |
| Q36780601 | The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. |
| Q54524811 | Vitamin A deficiency induces fluid hyposecretion from the airway submucosal glands of mice. |